HIC Precursor Removal via Dynamic Washing for rhNGF

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying recombinant human nerve growth factor (rhNGF) struggle to effectively remove precursor variants due to their similar physical and chemical properties to the mature rhNGF, making large-scale industrial production challenging, especially with hydrophobic interaction chromatography (HIC) methods that require expensive equipment and are not suitable for industrial use.

Innovation Solution

A dynamic washing approach using HIC with a Butyl Sepharose High Performance resin, employing a washing buffer with lower alcohol content and higher NaCl concentration than the elution buffer, and a specific washing volume determined by the peak area of the eluted product, effectively separates and removes rhNGF precursors from mature rhNGF.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If molecular sieve (Superdex 75) is used to remove precursor variants, then purity is improved, but equipment cost and operational complexity increase making it unsuitable for large-scale production

Engineering Contradiction:
ImprovepurityVSAvoidequipment complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent changes the chromatographic parameters by using HIC with specific buffer conditions (salt concentration, alcohol content) to separate precursors from mature rhNGF, replacing the molecular sieve method and enabling large-scale production

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If linear gradient elution is used in HIC to remove precursors, then purity is improved, but equipment requirements and operational complexity increase

Engineering Contradiction:
ImprovepurityVSAvoidoperational simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent segments the elution process into distinct steps (wash step with low alcohol/high salt, then elution step with high alcohol/low salt) rather than using continuous linear gradient elution, simplifying equipment requirements while maintaining purification effectiveness

Inventive Principle:
Principle #1Segmentation

3Manufacturing precision

If HIC with phenyl group is used to remove precursors, then purity is improved, but equipment cost and complexity increase for large-scale production

Engineering Contradiction:
ImprovepurityVSAvoidindustrial scalability
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent changes the HIC methodology by using butyl group resin with specific buffer compositions (phosphate buffer, alcohol, salt) and stepwise elution parameters that are more suitable for large-scale industrial production compared to phenyl group HIC

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves high precursor variant removal rates and product recovery rates, making it suitable for large-scale industrial production by efficiently purifying rhNGF through stepwise dynamic washing in HIC, as shown in statistical analysis results.

Implementation Method 1

hydrophobic interaction chromatography (HIC)

Methodology Applied
Scientific EffectHydrophobic interaction chromatography: Hydrophobe

Implementation Method 2

employing a washing buffer with lower alcohol content and higher NaCl concentration than the elution buffer

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS11220525B2Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatography
Publication Date: 2022.01.11 JIANGSU KANION PHARMA CO LTD
  • US11220525B2 patent drawing
  • US11220525B2 patent drawing
  • US11220525B2 patent drawing

AI summary

A method for removing precursors in recombinant human nerve growth factor (rhNGF) by hydrophobic interaction chromatography (HIC) is provided, where a Chinese hamster ovary (CHO) cell culture is processed by column chromatography for preliminary purification, and the pretreated sample obtained therefrom is further processed in a HIC column by washing the sample and then eluting the HIC column.